Medications

Patients missing out on arthritis drugs, shows study

A class of drugs that has been successfully treating patients with severe rheumatoid arthritis should be made available for moderate suffers, too, University of Manchester scientists say.

Medical research

Rheumatoid arthritic pain could be caused by antibodies

Antibodies that exist in the joints before the onset of rheumatoid arthritis can cause pain even in the absence of arthritis, researchers from Karolinska Institutet in Sweden report. The researchers believe that the finding, ...

Arthritis & Rheumatism

'Locking' an arthritis drug may be key to improving it

Attaching a removable lock to an arthritis drug can make it safer and more effective, according to a new study publishing June 13 in the open-access journal PLOS Biology led by Wen-Wei Lin of Kaohsiung Medical University, ...

Arthritis & Rheumatism

Rheumatoid arthritis—can its onset be delayed or prevented?

Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disorder that leads to significant health issues as well as high treatment costs. In this themed issue of Clinical Therapeutics, experts review multiple aspects ...

Arthritis & Rheumatism

New psoriatric arthritis mouse model developed

Psoriatic arthritis (PsA) is a chronic inflammatory disease that can reduce mobility and agility in patients. PsA is known to increase the risk of type II diabetes. A recent study published in The FASEB Journal tested a novel ...

Arthritis & Rheumatism

New option for treating active rheumatoid arthritis

In a large-scale, international study led by renowned rheumatologist Josef Smolen from the Department of Medicine III, a still-to-be-approved drug containing the selective janus kinase inhibitor upadacitinib has proved itself ...

page 1 from 4